These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19734416)
1. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Helbig G; Wieczorkiewicz A; Dziaczkowska-Suszek J; Majewski M; Kyrcz-Krzemien S Haematologica; 2009 Sep; 94(9):1236-41. PubMed ID: 19734416 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics of cytogenetics and molecular biology in patients with eosinophilia]. Qu SQ; Ai XF; Li CW; Li QH; Xu ZF; Qin TJ; Zhang Y; Xiao ZJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1216-20. PubMed ID: 23114151 [TBL] [Abstract][Full Text] [Related]
3. [Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome]. Zhang GS; Li B; Pei MF; Dai CW; Zheng WL; Shen JK Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1541-4. PubMed ID: 15500716 [TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study. Helbig G; Moskwa A; Hus M; Piszcz J; Swiderska A; Urbanowicz A; Całbecka M; Gajkowska J; Seferyńska I; Hałasz M; Woszczyk D; Markiewicz M; Krzemień S Hematol Oncol; 2010 Jun; 28(2):93-7. PubMed ID: 19728396 [TBL] [Abstract][Full Text] [Related]
5. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases. La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374 [TBL] [Abstract][Full Text] [Related]
6. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. Ogbogu PU; Bochner BS; Butterfield JH; Gleich GJ; Huss-Marp J; Kahn JE; Leiferman KM; Nutman TB; Pfab F; Ring J; Rothenberg ME; Roufosse F; Sajous MH; Sheikh J; Simon D; Simon HU; Stein ML; Wardlaw A; Weller PF; Klion AD J Allergy Clin Immunol; 2009 Dec; 124(6):1319-25.e3. PubMed ID: 19910029 [TBL] [Abstract][Full Text] [Related]
8. [The Lymphoid Variant of HES (L-HES) as Differential Diagnose of Severe Asthma in Childhood]. Leu T; Rauthe S; Wirth C; Simon HU; Kunzmann V; Hebestreit H; Kunzmann S Klin Padiatr; 2016 Nov; 228(6-07):319-324. PubMed ID: 27846662 [TBL] [Abstract][Full Text] [Related]
9. The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Yamada Y; Rothenberg ME; Lee AW; Akei HS; Brandt EB; Williams DA; Cancelas JA Blood; 2006 May; 107(10):4071-9. PubMed ID: 16418325 [TBL] [Abstract][Full Text] [Related]
10. A multicenter analysis of the FIP1L1-alphaPDGFR fusion gene in Japanese idiopathic hypereosinophilic syndrome: an aberrant splicing skipping the alphaPDGFR exon 12. Sada A; Katayama Y; Yamamoto K; Okuyama S; Nakata H; Shimada H; Oshimi K; Mori M; Matsui T; Ann Hematol; 2007 Dec; 86(12):855-63. PubMed ID: 17701174 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. Baccarani M; Cilloni D; Rondoni M; Ottaviani E; Messa F; Merante S; Tiribelli M; Buccisano F; Testoni N; Gottardi E; de Vivo A; Giugliano E; Iacobucci I; Paolini S; Soverini S; Rosti G; Rancati F; Astolfi C; Pane F; Saglio G; Martinelli G Haematologica; 2007 Sep; 92(9):1173-9. PubMed ID: 17666373 [TBL] [Abstract][Full Text] [Related]
12. FIP1L1-PDGFRA positive chronic eosinophilic leukemia in Tunisian patients. Menif S; Omri H; Hafsia R; Ben Romdhane N; Turki S; Meddeb B; Dellagi K Pathol Biol (Paris); 2007 Jun; 55(5):242-5. PubMed ID: 17137731 [TBL] [Abstract][Full Text] [Related]
13. [Studying of clinical and laboratory features of chronic eosinophilic leukemias /hypereosinophilic syndrome]. Zhang Y; Yu MH; Xu SC; Yang L; Yu Y; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):3-8. PubMed ID: 18512307 [TBL] [Abstract][Full Text] [Related]
14. Detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia. Cools J; Stover EH; Gilliland DG Methods Mol Med; 2006; 125():177-87. PubMed ID: 16502585 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. Rives S; Alcorta I; Toll T; Tuset E; Estella J; Cross NC J Pediatr Hematol Oncol; 2005 Dec; 27(12):663-5. PubMed ID: 16344672 [TBL] [Abstract][Full Text] [Related]
16. [Synchronous detection of T-cell clonality and FIP1L1-PDGFRA fusion gene in a hypereosinophilic syndrome]. Martinaud C; Souraud JB; Cournac JM; Pons S; Ménard G; de Jaureguiberry JP; Brisou P Rev Med Interne; 2011 May; 32(5):e66-8. PubMed ID: 20633965 [TBL] [Abstract][Full Text] [Related]
17. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Pardanani A; Ketterling RP; Brockman SR; Flynn HC; Paternoster SF; Shearer BM; Reeder TL; Li CY; Cross NC; Cools J; Gilliland DG; Dewald GW; Tefferi A Blood; 2003 Nov; 102(9):3093-6. PubMed ID: 12842979 [TBL] [Abstract][Full Text] [Related]
18. [Identification of clonal proliferation of T cell and FIP1L1-PDGFRalpha fusion gene in hypereosinophilic syndrome associated with lymphomatoid papulosis which showed rapid and complete response to the treatment with imatinib]. Fujimi A; Kanisawa Y; Kikuchi S; Okuda T; Sato Y; Doi T; Ohta H; Umeda I; Nobuoka A Nihon Naika Gakkai Zasshi; 2007 Dec; 96(12):2794-7. PubMed ID: 18203417 [No Abstract] [Full Text] [Related]
19. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib. Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197 [TBL] [Abstract][Full Text] [Related]
20. Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders. Gotlib J; Akin C Semin Hematol; 2012 Apr; 49(2):128-37. PubMed ID: 22449623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]